FDA Issues Approvable Letter to Ortec for Use of Cryopreserved OrCel(R) in Epidermolysis Bullosa Patients' Hand (PR Newswire via Yahoo! Finance)
Ortec International, Inc. , a company focused on advancing regenerative medicine through the development of cellular technology and advanced biomaterial products, has been notified by the Food and Drug Administration that its HDE Supplement is approvable subject to an inspection by the FDA of its commercial manufacturing facility.

FDA Approves Remicade for Severe Psoriasis (RedNova)
Johnson & Johnson unit Centocor has said that the FDA has approved Remicade for the treatment of patients with plaque psoriasis who are candidates for systemic therapy.